ROZLYTREK DIN 02495015
Status: Marketed
Holder: HOFFMANN-LA ROCHE LIMITED
Available to quote
Health Canada record
| Active ingredient(s) | ENTRECTINIB 200 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01EX14 ENTRECTINIB |
|---|
| Original market date | 04-Mar-2020 |
|---|
| Current status date | 04-Mar-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENTRECTINIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02495007 | ROZLYTREK | HOFFMANN-LA ROCHE LIMITED | Capsule | ENTRECTINIB 100 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23189 | 2020-02-10 | New Drug Submission (NDS) | |
Request a quote for ROZLYTREK
How to read a Canadian DIN record